On this episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz are joined by Dr. Eric Topol, a physician and writer who is widely recognized both as a leading researcher and a public voice on medicine and health. They discuss his career turn toward genomics and digital health, and the fight against misinformation on Twitter.
On the this episode of the Health & Veritas podcast, Harlan Krumholz reports on a unprecedented recall of ventilators and CPAP machines; Howard Forman discusses a new approach to tackling the issue of antimicrobial resistance. And they’re joined by Dr. Nancy Brown, dean of the Yale School of Medicine, to discuss her career path and her investments in developing talent.
In this episode of Health & Veritas podcast, Harlan Krumholz provides updates on R.S.V., flu, and COVID-19; Howard Forman considers the growing use of hallucinogens for treatment of severe depression. And they are joined by Dr. Vineet Arora, dean of medical education at the University of Chicago, to discuss the future of medical Twitter and how medical education is changing in the wake of the pandemic.
On this episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz are joined by Dr. Marcella Nunez-Smith, a Yale internist and nationally known expert on healthcare equity, to discuss her service in the Biden administration and the need for a broad approach to tackling racism in healthcare and systemic inequities in health.
On this episode of the Health & Veritas podcast, Harlan Krumholz describes a revealing new study on the long-term impacts of COVID; Howard Forman reflects on the escalating costs of health insurance. And they are joined by Dr. Lisa Leffert, Yale’s chief of anesthesiology, to discuss her unusual career path, disparities in maternal mortality, and her approach to tackling the gender pay gap in the field.
In this episode of the Health & Veritas podcast, Harlan Krumholz reports on a new study testing the effectiveness of the OCD drug fluvoxamine in treating COVID, and Howard Forman reflects on the potential of continuous glucose monitoring for people with diabetes. And they’re joined by Dr. Utibe Essien of the University of Pittsburgh to discuss the barriers preventing people of color from getting innovative new treatments and medications.
On this episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz check in on new research and health issues in the news, including studies on colonoscopies and the timing of hypertension medication, the state of the monkey pox and polio outbreaks, and the wave of legislation restricting treatment of trans youth.
In the wake of the Supreme Court’s Dobbs v. Jackson Women’s Health Organization decision, access to reproductive healthcare varies widely from state to state. In a recent Yale SOM conversation, alumni and faculty discussed how businesses can advocate for the preservation of that access on behalf of their employees, customers, and other stakeholders.
On this episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz look at the plunging cost of sequencing an individual genome, and the problem of concussions among athletes at all levels. And they’re joined by Dr. Ania Jastreboff, a Yale obesity specialist, to discuss the dramatic results from a new class of drugs that target the brain’s system for regulating body fat.
In this episode of the Health & Veritas podcast, Harlan Krumholz discusses the problem of “financial toxicity”—how medical bills can wreak havoc in vulnerable patients’ lives. Howard Forman reflects on the protests in Iran and the precariousness of the freedoms we enjoy in the United States. And they are joined by Ingrid Nembhard of the University of Pennsylvania to discuss her work on the organizational factors that shape patient care.
On this episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz react to President Joe Biden’s declaration that the pandemic is over. Then they’re joined by Jonathan Rothberg, a Yale-trained scientist who has created new methods for sequencing DNA and founded a series of successful biotech companies.